ConductScience.org, home

Paper6969693

Methodological implications of testing anaerobe susceptibility to cephalosporins (cefazolin, cefamandole, cefoxitin).

Krasemann C and 5 others. Infection, 1980. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Methodological implications of testing anaerobe susceptibility to cephalosporins (cefazolin, cefamandole, cefoxitin). Papers, record 6969693. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6969693

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Methodological implications of testing anaerobe susceptibility to cephalosporins (cefazolin, cefamandole, cefoxitin).
PubMed
Journal
Infection
PubMed
Year
1980
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.04
iCite
Revised in PubMed
2019-08-29
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Krasemann CC
2Werner HH
3Hildenbrand GG
4Benning MM
5Brandt UU
6Ungerechts JJ

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BacteroidaceaeMajor topic
CephalosporinsMajor topic
Microbial Sensitivity TestsMajor topic
PeptococcaceaeMajor topic
Cefamandole
Cefazolin
Cefoxitin
beta-Lactamases

Source PubMed

Download CSV of topics

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1168701[A new butyric acid-producing bacteroides species: B. splanchnicus n. sp. (author's transl)].Zentralbl Bakteriol Orig A1975https://conductscience.org/library/papers/168701PubMed
2949182Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteria.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/949182PubMed
3984809Susceptibility of anaerobic bacteria to 23 antimicrobial agents.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/984809PubMed
44210470Differentiation and medical importance of saccharolytic intestinal Bacteroides.Arzneimittelforschung1974https://conductscience.org/library/papers/4210470PubMed
55083607A comparative study of 55 Sphaerophorus strains. Differentiation of 3 species: Sphaerophorus necrophorus, Sph, varius, and Sph. freundii.Med Microbiol Immunol1972https://conductscience.org/library/papers/5083607PubMed
65147789A biochemical study of fusiform anaerobes.Med Microbiol Immunol1971https://conductscience.org/library/papers/5147789PubMed
7314805Susceptibility to cefazedone and cefazolin and production of beta-lactamase in in Bacteroides fragilis and other species of Bacteroidaceae.Arzneimittelforschung1979https://conductscience.org/library/papers/314805PubMed
845494Purification and properties of beta-lactamase from Bacteroides fragilis.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/45494PubMed
9938021Comparison of in vitro antimicrobial activity of cefamandole and cefazolin with cephalothin against over 8,000 clinical bacterial isolates.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/938021PubMed
101179870[Susceptibility to tetracycline and doxycycline of 80 strains of Bacteroides fragilis, B, thetaiotaomicron, and B. vulgatus mostly isolated in 1973/74 (author's transl)].Zentralbl Bakteriol Orig A1975https://conductscience.org/library/papers/1179870PubMed
11856025Cefoxitin resistance to beta-lactamase: a major factor for susceptibility of bacteroides fragilis to the antibiotic.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/856025PubMed
124146824[Anaerobic gram-positive cocci (Peptococcus variabilis, P. asaccharolyticus, P. prevotii and P. saccharolyticus) isolated from pathological material].Zentralbl Bakteriol Orig A1973https://conductscience.org/library/papers/4146824PubMed
131180547Comparison of cefoxitin and cephalothin therapy of a mixed Bacteroides fragilis and Fusobacterius necrophorum infection in mice.Antimicrob Agents Chemother1975https://conductscience.org/library/papers/1180547PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
8051254Evaluation of Alamar colorimetric MIC method for antimicrobial susceptibility testing of gram-negative bacteria.J Clin Microbiol1994https://conductscience.org/library/papers/8051254

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6969693

GET https://conductscience.org/api/papers/v1/6969693/authors